German drugmaker Stada Arzneimittel AG could break open the market for European initial public offerings again as it gears up ...

The Miami-based hedge fund is poised to slash the size of its local workspace and move it to River North. But another firm is ...

The catalyst for the crisis at Fuji was a report by a local tabloid in December that a prominent TV host sexually harassed a woman. The star, Masahiro Nakai, acknowledged ‘trouble’ for which he ...

Fuji Media Holdings Inc. has had an abysmal start to 2025. The broadcaster’s reputation is in tatters as a sexual harassment ...

Industry Funds Management (IFM) has won a $100-million mandate from health and community services industry superannuation fund HESTA, which wants its Australian stock investments to produce as little ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Brookfield offered A$4.60 per share for Insignia and has been granted limited access to its books, according to a statement ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.